GLP-1 microdosing is when people take smaller doses of GLP-1 drugs than are typically prescribed or FDA-recommended, often ...
Terrestrial Bio has dosed the first patients in a Phase I clinical trial evaluating its patch that delivers GLP-1 therapeutic ...
Scientists at The Wistar Institute have shown that a single injection of a small, circular piece of genetic instructions can ...
Landmark agreement between a leading virtual care company and a pharmaceutical manufacturer establishes an exclusive telehealth co-marketing ...
Management of congenital adrenal hyperplasia (CAH) requires a multidisciplinary team with expertise in CAH to ensure a comprehensive, patient-centered approach (Figure 5-1). Responsibilities within ...
Nilofer recalls a time when IVF felt something out of reality from her own life. "During my college days, I'd walk past so many fertility and IVF clinics in South Delhi on my way to class. I never ...
Celltrion Testing Access Program Expands Availability of Therapeutic Drug Monitoring to Support Patient Transition to Subcutaneous Infliximab JERSEY CITY, NJ AND SAN DIEGO, CA / ACCESS Newswire / July ...
VANCOUVER, BC / ACCESS Newswire / July 6, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery syste ...
Psychologist Albert Bandura developed his self-efficacy theory in the late 1970s. Bandura defined self-efficacy as “a person’s beliefs about how capable he or she is in performing the behaviors needed ...
Osteoarthritis affects around 600 million people globally. It causes pain, stiffness and reduced joint function – most commonly in the knees, hands and hips. There’s currently no cure for ...
Knee osteoarthritis is a complex disease that affects the whole joint, including bone, cartilage, ligaments and muscles. Osteoarthritis is a common cause of pain and movement difficulty, affecting 8.3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results